# Primrose Therapeutics, Inc. — Form D

Primrose Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-13. The offering totals $1.5M, of which $753K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2010-08-13
- Form: D
- Accession: 0001499169-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.5M
- Amount sold: $753K
- Remaining: $750K
- Investors: 1
- Date of first sale: 2010-07-30
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-146420

## Issuer

- Name: Primrose Therapeutics, Inc.
- CIK: 0001499169
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 875 THIRD AVENUE, NEW YORK, NY, 10022
- Phone: 212-632-5404

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| JEFFREY S EDELMAN | Director | NEW YORK, NY |
| Mark S Kessel | Director | New York, NY |
| ZACHARY S SHARON | Director | NEW YORK, NY |
| JEFFREY S EDELMAN | Executive Officer | NEW YORK, NY |
| Mark S Kessel | Executive Officer | New York, NY |
| ZACHARY S SHARON | Executive Officer | NEW YORK, NY |

## More

- [CIK 1499169 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1499169&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001499169-10-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.